EUVIMEDEUVIMED entdecken
Crossref

Hemoglobin Variant or Interference?

Carmen García Rabaneda iD, Manuel Ruiz Artero, Azahara Jordano Montilla, Yenifer Gamarra Morales, Félix Gascón Luna

Clinical Chemistry · 2023

DOI: 10.1093/clinchem/hvad047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2023. Verfasst von Carmen García Rabaneda und 4 weiteren Autor:innen. Beteiligte Einrichtung: UGC Análisis Clínicos, Hospital Valle de los Pedroches, Córdoba, Spain. Hauptthemen laut MEDLINE: Hematologic Tests, Hemoglobins, Abnormal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The patient was a 72-year-old male with type 2 diabetes mellitus. A blood count was determined during his annual follow-up for diabetes mellitus. During chromatography on a Tosoh G8 analyzer using an ion-exchange method, the equipment alerted that there was a possible heterozygous variant (26.1%) that interfered with the HbA1c value (Fig. 1, A). Upon review of the patient's medical and chromatogram history, it was noted that he had not been previously diagnosed with a hemoglobinopathy (Fig. 1, B). Two chromatograms were performed in 2 different years to control glycosylated hemoglobin. (A), Second chromatogram with the Hb variant detected; (B), Previous chromatogram with the Hb variant hidden at 0.85 min. Abbreviations: A1A, glycated hemoglobin A1A; A1B, glycated hemoglobin A1B; F, fetal hemoglobin; LA1C+, labile glycated hemoglobin by glucose; SA1C, stable glycated hemoglobin by glucose; P00, abnormal peak; A0, Hemoglobin A0. Can a hemoglobin variant that has not been previously identified get detected by ion-exchange chromatography? What parameters should be checked in the chromatogram to verify the presence of a variant? What is the recommended confirmatory test in this case? High levels (>3.5%) of HbLA1c indicate that there is the possibility of a hidden variant (1) and therefore it is important to check this parameter in the chromatograms. The variant produces a change in the charge and the variant fraction cannot be separated because it coelutes with HbLA1c, causing interference with ion-exchange HPLC (2). Confirmatory testing by PCR using the StripAssay commercial kit revealed a heterozygous HBA2 variant (NM_000517.6, c.63C > A p.(His21Gln)), consistent with Le Lamentin hemoglobinopathy. The corresponding author takes full responsibility that all authors on this publication have met the following required criteria of eligibility for authorship: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; (c) final approval of the published article; and (d) agreement to be accountable for all aspects of the article thus ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved. Nobody who qualifies for authorship has been omitted from the list. Carmen García Rabaneda (Investigation-Lead, Writing—original draft-Lead), Manuel Ruiz Artero (Conceptualization-Supporting, Investigation-Supporting, Writing—review & editing-Supporting), Azahara Jordano Montilla (Investigation-Supporting, Writing—review & editing-Supporting), Yenifer Gamarra Morales (Supervision-Supporting, Writing—review & editing-Supporting), and Félix Gascón Luna (Conceptualization-Lead, Supervision-Lead, Validation-Lead, Writing—review & editing-Supporting) No authors declared any potential conflicts of interest. The authors had not any financial support.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic TestsHemoglobins, AbnormalHumansGlycated HemoglobinChromatography, High Pressure Liquid

Substanzen

Glycated HemoglobinHemoglobins, Abnormal

Autor:innen und Institutionen

  • UGC Análisis Clínicos, Hospital Valle de los Pedroches, Córdoba, Spain.

ORCID-Profile: Carmen García Rabaneda

Zitieren

APA

García Rabaneda, C., Ruiz Artero, M., Jordano Montilla, A., Gamarra Morales, Y., & Gascón Luna, F. (2023). Hemoglobin Variant or Interference?. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvad047

Vancouver

García Rabaneda C, Ruiz Artero M, Jordano Montilla A, Gamarra Morales Y, Gascón Luna F. Hemoglobin Variant or Interference?. Clinical Chemistry. 2023. doi:10.1093/clinchem/hvad047

BibTeX
@article{GarcaRabaneda2023,
  author = {García Rabaneda, Carmen and Ruiz Artero, Manuel and Jordano Montilla, Azahara and Gamarra Morales, Yenifer and Gascón Luna, Félix},
  title = {Hemoglobin Variant or Interference?},
  journal = {Clinical Chemistry},
  year = {2023},
  doi = {10.1093/clinchem/hvad047}
}
Kostenlos starten →